Intuitive Appoints Amy L. Ladd, M.D. to its Board of Directors
29 Julho 2019 - 5:15PM
Intuitive (Nasdaq: ISRG), a global technology leader in minimally
invasive care and the pioneer of robotic-assisted surgery, today
announced the appointment of Amy L. Ladd, M.D., from Stanford
University Medical Center to its board of directors,
effective Aug. 1, 2019.
“Dr. Ladd brings deep surgical and medical
perspective to our board of directors,” said Intuitive
CEO Gary Guthart. “We are excited to welcome her and look
forward to her contributions.”
Dr. Ladd has spent nearly three decades
practicing orthopaedic surgery at Stanford University, specializing
in hand surgery and research focused on deciphering the progression
and treatment of common basilar thumb arthritis. She currently
serves as the Elsbach-Richards Professor of Surgery, and by
courtesy, Professor of Medicine (Immunology & Rheumatology) at
the Stanford University Medical Center. She holds ten patents and
trademarks for innovation that include treatment for wrist
fractures, thumb arthritis and that promote musculoskeletal health
awareness.
Dr. Ladd also served as the chair of the
American Academy of Orthopaedic Surgeons (AAOS) Board of
Specialties Society and is a past member of the AAOS board of
directors. She previously served as president of the Ruth
Jackson Orthopaedic Society.
Dr. Ladd received her M.D. from SUNY Upstate
Medical University, completed Orthopaedic Residency at the
University of Rochester, and completed the Harvard Combined Hand
Surgery Fellowship. Dr. Ladd was a fellow at L'Institut de la Main
in Paris, France prior to joining the Stanford University faculty
in 1990. She completed her undergraduate degree in History at
Dartmouth College.
About Intuitive
Intuitive (Nasdaq: ISRG), headquartered
in Sunnyvale, Calif., is a global technology leader in
minimally invasive care and the pioneer of robotic-assisted
surgery. At Intuitive, we believe that minimally invasive care is
life-enhancing care. Through ingenuity and intelligent technology,
we expand the potential of physicians to heal without
constraints.
Intuitive brings more than two decades of
leadership in robotic-assisted surgical technology and solutions to
its offerings, and develops, manufactures and markets the
da Vinci® surgical system and the Ion™ endoluminal
system.
About the da Vinci Surgical
System
There are several models of
the da Vinci surgical system.
The da Vinci surgical systems are designed to help
surgeons perform minimally invasive surgery.
Da Vinci systems offer surgeons high-definition 3D
vision, a magnified view, and robotic and computer assistance. They
use specialized instrumentation, including a miniaturized surgical
camera and wristed instruments (i.e., scissors, scalpels and
forceps) that are designed to help with precise dissection and
reconstruction deep inside the body.
For more information, please visit the company’s
website at www.intuitive.com.
ContactGlobal Public AffairsIntuitive
Surgicalcorp.comm@intusurg.com+1-408-523-7337
Intuitive Surgical (NASDAQ:ISRG)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Intuitive Surgical (NASDAQ:ISRG)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025